Trial Profile
An open label, single centre, assessor blind pilot study comparing topical tacrolimus 0.1% and hydrocortisone ointment 1% in the treatment of flexural psoriasis.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 11 Nov 2019
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Hydrocortisone
- Indications Inverse psoriasis
- Focus Therapeutic Use
- 09 Nov 2019 Status changed from recruiting to discontinued.
- 24 Jul 2011 New trial record